Adelene Q. Perkins
2020
In 2020, Adelene Q. Perkins earned a total compensation of $2.7M as Chief Executive Officer at Infinity Pharmaceuticals, a 63% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $448,230 |
|---|---|
| Option Awards | $1,399,928 |
| Salary | $689,585 |
| Stock Awards | $193,918 |
| Other | $11,429 |
| Total | $2,743,090 |
Perkins received $1.4M in option awards, accounting for 51% of the total pay in 2020.
Perkins also received $448.2K in non-equity incentive plan, $689.6K in salary, $193.9K in stock awards and $11.4K in other compensation.
Rankings
In 2020, Adelene Q. Perkins' compensation ranked 4,202nd out of 13,090 executives tracked by ExecPay. In other words, Perkins earned more than 67.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,202 out of 13,090 | 68th |
Division Manufacturing | 1,699 out of 5,624 | 70th |
Major group Chemicals And Allied Products | 656 out of 2,257 | 71st |
Industry group Drugs | 561 out of 1,957 | 71st |
Industry Pharmaceutical Preparations | 427 out of 1,462 | 71st |
Source: SEC filing on April 26, 2021.
Perkins' colleagues
We found two more compensation records of executives who worked with Adelene Q. Perkins at Infinity Pharmaceuticals in 2020.